Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE: 000766)

Market Cap	15.17B
Revenue (ttm)	1.47B
Net Income (ttm)	43.93M
Shares Out	966.49M
EPS (ttm)	0.05
PE Ratio	345.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,694,700
Open	15.39
Previous Close	15.23
Day's Range	15.02 - 15.39
52-Week Range	12.12 - 20.95
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 18, 2025

About Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides bone peptides, protective chemical medicines, cardiovascular and cerebrovascular chinese patent medicines, heat-clearing and detoxifying medicines, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 1,696
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000766

Financial Performance

In 2023, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's revenue was 1.47 billion, an increase of 0.18% compared to the previous year's 1.47 billion. Earnings were 43.93 million, an increase of 45.71%.